Attached files

file filename
S-1 - FORM S-1 - Nexvet Biopharma plcd775834ds1.htm
EX-10.18 - EX-10.18 - Nexvet Biopharma plcd775834dex1018.htm
EX-4.2 - EX-4.2 - Nexvet Biopharma plcd775834dex42.htm
EX-10.12 - EX-10.12 - Nexvet Biopharma plcd775834dex1012.htm
EX-10.4 - EX-10.4 - Nexvet Biopharma plcd775834dex104.htm
EX-10.16 - EX-10.16 - Nexvet Biopharma plcd775834dex1016.htm
EX-10.13 - EX-10.13 - Nexvet Biopharma plcd775834dex1013.htm
EX-10.7 - EX-10.7 - Nexvet Biopharma plcd775834dex107.htm
EX-4.3 - EX-4.3 - Nexvet Biopharma plcd775834dex43.htm
EX-21.1 - EX-21.1 - Nexvet Biopharma plcd775834dex211.htm
EX-10.11 - EX-10.11 - Nexvet Biopharma plcd775834dex1011.htm
EX-10.8 - EX-10.8 - Nexvet Biopharma plcd775834dex108.htm
EX-3.2 - EX-3.2 - Nexvet Biopharma plcd775834dex32.htm
EX-10.9 - EX-10.9 - Nexvet Biopharma plcd775834dex109.htm
EX-10.14 - EX-10.14 - Nexvet Biopharma plcd775834dex1014.htm
EX-10.5 - EX-10.5 - Nexvet Biopharma plcd775834dex105.htm
EX-10.15 - EX-10.15 - Nexvet Biopharma plcd775834dex1015.htm
EX-16.1 - EX-16.1 - Nexvet Biopharma plcd775834dex161.htm
EX-10.19 - EX-10.19 - Nexvet Biopharma plcd775834dex1019.htm
EX-10.2 - EX-10.2 - Nexvet Biopharma plcd775834dex102.htm
EX-10.10 - EX-10.10 - Nexvet Biopharma plcd775834dex1010.htm
EX-10.6 - EX-10.6 - Nexvet Biopharma plcd775834dex106.htm
EX-10.1 - EX-10.1 - Nexvet Biopharma plcd775834dex101.htm
EX-3.1 - EX-3.1 - Nexvet Biopharma plcd775834dex31.htm
EX-23.2 - EX-23.2 - Nexvet Biopharma plcd775834dex232.htm
EX-10.3 - EX-10.3 - Nexvet Biopharma plcd775834dex103.htm
EX-10.17 - EX-10.17 - Nexvet Biopharma plcd775834dex1017.htm

Exhibit 99.1

CONSENT OF RAJIV PATEL

Pursuant to Rule 438 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents to being named in the registration statement on Form S-1 and in all subsequent amendments or supplements thereto and in any registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act (collectively, the “Registration Statement”) of Nexvet Biopharma public limited company (the “Company”) as an individual to become a director of the Company and to the inclusion of his biographical and other information in the Registration Statement. The undersigned further consents to the filing of this consent as an exhibit to the Registration Statement.

The undersigned also hereby consents to being named in any registration statement on Form S-8 filed by the Company that incorporates by reference the prospectus forming part of the Registration Statement.

In witness whereof, this consent is signed and dated as of the date set forth below.

 

/s/ Rajiv Patel

Name:  

Rajiv Patel

Date:  

Dec. 30, 2014